TNFAIP8: A New Effector for Galpha(i) Coupling to Reduce Cell Death and Induce Cell Transformation

被引:47
作者
Laliberte, Benoit [1 ]
Wilson, Ariel M. [1 ]
Nafisi, Houman [1 ]
Mao, Helen [1 ]
Zhou, Yi Yuen [1 ]
Daigle, Mireille [1 ]
Albert, Paul R. [1 ]
机构
[1] Univ Ottawa, Ottawa Hosp Res, Inst Neurosci, Ottawa, ON K1H 8M5, Canada
基金
加拿大健康研究院;
关键词
ACTIVATED PROTEIN-KINASE; G-BETA-GAMMA; BALB/C; 3T3-CELLS; MAMMARY TUMORIGENESIS; PROLACTIN SECRETION; MEDIATED APOPTOSIS; ADENYLYL-CYCLASE; PITUITARY-CELLS; DNA-SYNTHESIS; IN-VITRO;
D O I
10.1002/jcp.22297
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Galpha(i)-coupled receptors comprise a diverse family of receptors that induce transformation by largely unknown mechanisms. We previously found that the Galpha(i)-coupled dopamine-D2short (D2S) receptor transforms Balb-D2S cells via G alpha i3. To identify new G alpha i effectors, a yeast two-hybrid screen was done using constitutively active G alpha i3-Q204L as bait, and tumor necrosis factor-alpha (TNF alpha)-induced protein 8 (TNFAIP8, SCC-S2/NDED/GG2-I) was identified. In contrast, TNFAIP8-related TIPE1 and TIPE2 showed a very weak interaction with G alpha i3. In yeast mating, in vitro pull-down, co-immunoprecipitation and bioluminescence resonance energy transfer (BRET) assays, TNFAIP8 preferentially interacted with activated G alpha i proteins, consistent with direct G alpha i-INFAIP8 coupling. Overexpression or depletion of TNFAIP8 using antisense constructs in Balb-D2S cells did not affect D2S-induced signaling to G alpha i-dependent inhibition of cAMP. In contrast, antisense depletion of TNFAIP8 completely inhibited spontaneous and D2S-induced foci formation, consistent with a role for TNFAIP8 in G alpha i-dependent transformation. To address possible mechanisms, the effect of D2S signaling via TNFAIP8 on TNF alpha action was examined. D2S receptor activation inhibited TNF alpha-induced cell death in Balb-D2S cells, but not in cells depleted of TNFAIP8. However, depletion of TNFAIP8 did not prevent D2S-induced inhibition of TNF alpha-mediated caspase activation, suggesting that D2S/TNFAIP8-induced protection from TNF alpha-induced cell death is caspase-independent. The data suggest that G alpha i-TNFAIP8-mediated rescue of pre-oncogenic cells enhances progression to oncogenic transformation, providing a selective target to inhibit cellular transformation. J. Cell. Physiol. 225: 865-874, 2010. (C) 2010 Wiley-Liss, Inc.
引用
收藏
页码:865 / 874
页数:10
相关论文
共 40 条
[1]  
Albert Paul R., 1997, P359
[2]   Constitutive Gi2-dependent activation of adenylyl cyclase type II by the 5-HT1A receptor -: Inhibition by anxiolytic partial agonists [J].
Albert, PR ;
Sajedi, N ;
Lemonde, S ;
Ghahremani, MH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (50) :35469-35474
[3]   HETEROLOGOUS EXPRESSION OF G-PROTEIN-LINKED RECEPTORS IN PITUITARY AND FIBROBLAST CELL-LINES [J].
ALBERT, PR .
VITAMINS AND HORMONES - ADVANCES IN RESEARCH AND APPLICATIONS, VOL 48, 1994, 48 :59-109
[4]   G protein preferences for dopamine D2 inhibition of prolactin secretion and DNA synthesis in GH4 pituitary cells [J].
Albert, PR .
MOLECULAR ENDOCRINOLOGY, 2002, 16 (08) :1903-1911
[5]   G protein specificity: Traffic direction required [J].
Albert, PR ;
Robillard, L .
CELLULAR SIGNALLING, 2002, 14 (05) :407-418
[6]   Targeting the extrinsic apoptosis pathway in cancer [J].
Ashkenazi, Avi .
CYTOKINE & GROWTH FACTOR REVIEWS, 2008, 19 (3-4) :325-331
[7]   Dopamine-D2S receptor inhibition of calcium influx, adenylyl cyclase, and mitogen-activated protein kinase in pituitary cells:: Distinct Gα and Gβγ requirements [J].
Banihashemi, B ;
Albert, PR .
MOLECULAR ENDOCRINOLOGY, 2002, 16 (10) :2393-2404
[8]  
Bockaert J, 2002, INT REV CYTOL, V212, P63
[9]   Heterotrimeric G-Proteins Interact Directly with Cytoskeletal Components to Modify Microtubule-Dependent Cellular Processes [J].
Dave, Rahul H. ;
Saengsawang, Witchuda ;
Yu, Jiang-Zhou ;
Donati, Robert ;
Rasenick, Mark M. .
NEUROSIGNALS, 2009, 17 (01) :100-108
[10]   Death receptors in chemotherapy and cancer [J].
Debatin, KM ;
Krammer, PH .
ONCOGENE, 2004, 23 (16) :2950-2966